Prenatal diagnosis of hemoglobin disorders: Present and future strategies

Kan, 1978, Antenatal diagnosis of sickle-cell anaemia by D.N.A. analysis of amniotic-fluid cells, Lancet, 2, 910, 10.1016/S0140-6736(78)91629-X Gaziev, 2008, Hematopoietic stem cell transplantation in thalassemia, Bone. Marrow. Transplant., 42, S41, 10.1038/bmt.2008.112 Sadelain, 2008, Stem cell engineering for the treatment of severe hemoglobinopathies, Curr. Mol. Med., 8, 690, 10.2174/156652408786241357 Tabor, 1986, Randomised controlled trial of genetic amniocentesis in 4606 low-risk women, Lancet, 1, 1287, 10.1016/S0140-6736(86)91218-3 Hahn, 2008, Noninvasive prenatal diagnosis: current practice and future perspectives, Curr. Opin. Obstet. Gynecol., 20, 146, 10.1097/GCO.0b013e3282f73349 Handyside, 1990, Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification, Nature, 344, 768, 10.1038/344768a0 Kanavakis, 2002, Preimplantation genetic diagnosis in clinical practice, J. Med. Genet., 39, 6, 10.1136/jmg.39.1.6 Renwick, 2007, Preimplantation genetic diagnosis for monogenic diseases: overview and emerging issues, Expert. Rev. Mol. Diagn., 7, 33, 10.1586/14737159.7.1.33 Thornhill, 2005, ESHRE PGD Consortium ‘Best practice guidelines for clinical preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS)’, Hum. Reprod., 20, 35, 10.1093/humrep/deh579 Practice Committee of Society for Assisted Reproductive Technology; Practice Committee of American Society for Reproductive Medicine. Preimplantation genetic testing: a Practice Committee opinion. Fertil Steril 2008;90:S136–43. Old, 2003, Screening and genetic diagnosis of haemoglobin disorders, Blood. Rev., 17, 43, 10.1016/S0268-960X(02)00061-9 Old, 2003, Prevention of thalasaemia and other haemoglobin disorders, Vol. 1 Decorte, 1990, Rapid detection of hypervariable regions by the polymerase chain reaction technique, DNA. Cell. Biol., 9, 461, 10.1089/dna.1990.9.461 Ristaldi, 1989, Prenatal diagnosis of beta-thalassaemia in Mediterranean populations by dot blot analysis with DNA amplification and allele specific oligonucleotide probes, Prenat. Diagn., 9, 629, 10.1002/pd.1970090906 Saiki, 1989, Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes, Proc. Natl. Acad. Sci. U. S. A., 86, 6230, 10.1073/pnas.86.16.6230 Maggio, 1993, Rapid and simultaneous typing of hemoglobin S, hemoglobin C, and seven Mediterranean beta-thalassemia mutations by covalent reverse dot-blot analysis: application to prenatal diagnosis in Sicily, Blood, 81, 239, 10.1182/blood.V81.1.239.239 Sutcharitchan, 1995, Reverse dot-blot detection of Thai beta-thalassaemia mutations, Br. J. Haematol., 90, 809, 10.1111/j.1365-2141.1995.tb05200.x Sutcharitchan, 1995, Reverse dot-blot detection of the African-American beta-thalassemia mutations, Blood, 86, 1580, 10.1182/blood.V86.4.1580.bloodjournal8641580 Winichagoon, 1999, Prenatal diagnosis of beta-thalassaemia by reverse dot-blot hybridization, Prenat. Diagn., 19, 428, 10.1002/(SICI)1097-0223(199905)19:5<428::AID-PD563>3.0.CO;2-0 Gemignani, 2002, Reliable detection of beta-thalassemia and G6PD mutations by a DNA microarray, Clin. Chem., 48, 2051, 10.1093/clinchem/48.11.2051 Bang-Ce, 2004, Simultaneous detection of alpha-thalassemia and beta-thalassemia by oligonucleotide microarray, Haematologica, 89, 1010 Cremonesi, 2007, An overview of current microarray-based human globin gene mutation detection methods, Hemoglobin, 31, 289, 10.1080/03630260701459366 Newton, 1989, Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS), Nucleic Acids Res., 17, 2503, 10.1093/nar/17.7.2503 Tan, 1994, The amplification refractory mutation system (ARMS): a rapid and direct prenatal diagnostic technique for beta-thalassaemia in Singapore, Prenat. Diagn., 14, 1077, 10.1002/pd.1970141112 Tan, 2001, A rapid and reliable 7-deletion multiplex polymerase chain reaction assay for alpha-thalassemia, Blood, 98, 250, 10.1182/blood.V98.1.250 Chong, 2000, Single-tube multiplex-PCR screen for common deletional determinants of alpha-thalassemia, Blood, 95, 360, 10.1182/blood.V95.1.360 Liu, 2000, Rapid detection of alpha-thalassaemia deletions and alpha-globin gene triplication by multiplex polymerase chain reactions, Br. J. Haematol., 108, 295, 10.1046/j.1365-2141.2000.01870.x Old, 1990, Rapid detection and prenatal diagnosis of beta-thalassaemia: studies in Indian and Cypriot populations in the UK, Lancet, 336, 834, 10.1016/0140-6736(90)92338-I Craig, 1994, Rapid detection of deletions causing delta beta thalassemia and hereditary persistence of fetal hemoglobin by enzymatic amplification, Blood, 83, 1673, 10.1182/blood.V83.6.1673.1673 Myers, 1987, Detection and localization of single base changes by denaturing gradient gel electrophoresis, Methods Enzymol., 155, 501, 10.1016/0076-6879(87)55033-9 Fodde, 1994, Mutation detection by denaturing gradient gel electrophoresis (DGGE), Hum. Mutat., 3, 83, 10.1002/humu.1380030202 Losekoot, 1990, Denaturing gradient gel electrophoresis and direct sequencing of PCR amplified genomic DNA: a rapid and reliable diagnostic approach to beta thalassaemia, Br. J. Haematol., 76, 269, 10.1111/j.1365-2141.1990.tb07883.x O'Donovan, 1998, Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection, Genomics, 52, 44, 10.1006/geno.1998.5411 Li, 2008, Rapid genotyping of known mutations and polymorphisms in beta-globin gene based on the DHPLC profile patterns of homoduplexes and heteroduplexes, Clin. Biochem., 41, 681, 10.1016/j.clinbiochem.2008.02.008 Su, 2003, Rapid detection of beta-globin gene (HBB) mutations coupling heteroduplex and primer-extension analysis by DHPLC, Hum. Mutat., 22, 326, 10.1002/humu.10265 Colosimo, 2003, Validation of dHPLC for molecular diagnosis of beta-thalassemia in Southern Italy, Genet. Test., 7, 269, 10.1089/109065703322537322 Thein, 1989, Molecular characterization of a high A2 beta thalassemia by direct sequencing of single strand enriched amplified genomic DNA, Blood, 73, 924, 10.1182/blood.V73.4.924.924 Traeger-Synodinos JH, CL. Disease services: haemoglobinopathies, in Molecular Diagnosis of Genetic Disease. In: Elles R, Wallace A, ed., Vol., in press. Schouten, 2002, Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification, Nucleic Acids Res., 30, e57, 10.1093/nar/gnf056 White, 2004, Two-color multiplex ligation-dependent probe amplification: detecting genomic rearrangements in hereditary multiple exostoses, Hum. Mutat., 24, 86, 10.1002/humu.20054 Harteveld, 2005, Nine unknown rearrangements in 16p13.3 and 11p15.4 causing alpha- and beta-thalassaemia characterised by high resolution multiplex ligation-dependent probe amplification, J. Med. Genet., 42, 922, 10.1136/jmg.2005.033597 Harteveld, 2007, Refinement of the genetic cause of ATR-16, Hum. Genet., 122, 283, 10.1007/s00439-007-0399-y Charbonnier, 2000, Detection of exon deletions and duplications of the mismatch repair genes in hereditary nonpolyposis colorectal cancer families using multiplex polymerase chain reaction of short fluorescent fragments, Cancer. Res., 60, 2760 Ferec, 2006, Gross genomic rearrangements involving deletions in the CFTR gene: characterization of six new events from a large cohort of hitherto unidentified cystic fibrosis chromosomes and meta-analysis of the underlying mechanisms, Eur. J. Hum. Genet., 14, 567, 10.1038/sj.ejhg.5201590 Gouas, 2008, Gene dosage methods as diagnostic tools for the identification of chromosome abnormalities, Pathol. Biol. (Paris), 56, 345, 10.1016/j.patbio.2008.03.010 Saugier-Veber, 2006, Simple detection of genomic microdeletions and microduplications using QMPSF in patients with idiopathic mental retardation, Eur. J. Hum. Genet., 14, 1009, 10.1038/sj.ejhg.5201661 Rose, 2009, A novel (epsilongammadeltabeta)(o)-thalassemia deletion associated with an alpha globin gene triplication leading to a severe transfusion dependent fetal thalassemic syndrome, Haematologica, 94, 593, 10.3324/haematol.2008.002675 Vrettou, 2003, Rapid screening of multiple beta-globin gene mutations by real-time PCR on the LightCycler: application to carrier screening and prenatal diagnosis of thalassemia syndromes, Clin. Chem., 49, 769, 10.1373/49.5.769 Costa, 2003, A one-step real-time PCR assay for rapid prenatal diagnosis of sickle cell disease and detection of maternal contamination, Mol. Diagn., 7, 45, 10.2165/00066982-200307010-00008 Reed, 2007, High-resolution DNA melting analysis for simple and efficient molecular diagnostics, Pharmacogenomics, 8, 597, 10.2217/14622416.8.6.597 Wittwer, 2003, High-resolution genotyping by amplicon melting analysis using LCGreen, Clin. Chem., 49, 853, 10.1373/49.6.853 Herrmann, 2006, Amplicon DNA melting analysis for mutation scanning and genotyping: cross-platform comparison of instruments and dyes, Clin. Chem., 52, 494, 10.1373/clinchem.2005.063438 Herrmann, 2006, Instrument comparison for heterozygote scanning of single and double heterozygotes: a correction and extension of Herrmann et al., Clin. Chem., 52, 494, 10.1373/clinchem.2005.063438 Prathomtanapong, 2009, Detection and identification of beta-thalassemia 3.5 kb deletion by SYBR Green1 and high resolution melting analysis, Eur. J. Haematol., 82, 159, 10.1111/j.1600-0609.2008.01173.x Zhou, 2004, Closed-tube genotyping with unlabeled oligonucleotide probes and a saturating DNA dye, Clin. Chem., 50, 1328, 10.1373/clinchem.2004.034322 Colosimo, 2002, Reliability of DHPLC in mutational screening of beta-globin (HBB) alleles, Hum. Mutat., 19, 287, 10.1002/humu.10046 Pornprasert, 2008, Analysis of real-time SYBR-polymerase chain reaction cycle threshold for diagnosis of the alpha-thalassemia-1 Southeast Asian type deletion: application to carrier screening and prenatal diagnosis of Hb Bart's hydrops fetalis, Hemoglobin, 32, 393, 10.1080/03630260701798367 Gundry, 2003, Amplicon melting analysis with labeled primers: a closed-tube method for differentiating homozygotes and heterozygotes, Clin. Chem., 49, 396, 10.1373/49.3.396 Liew, 2004, Genotyping of single-nucleotide polymorphisms by high-resolution melting of small amplicons, Clin. Chem., 50, 1156, 10.1373/clinchem.2004.032136 Herrmann, 2000, Rapid beta-globin genotyping by multiplexing probe melting temperature and color, Clin. Chem., 46, 425, 10.1093/clinchem/46.3.425 Goossens, 2008, ESHRE PGD Consortium data collection VIII: cycles from January to December 2005 with pregnancy follow-up to October 2006, Hum. Reprod., 23, 2629, 10.1093/humrep/den238 Goossens V, Harton G, Moutou C, Traeger-Synodinos J, Van Rij M, Harper JC. ESHRE PGD Consortium data collection IX: cycles from January to December 2006 with pregnancy follow-up to October 2007 Hum Reprod 2009;24:1786–810. Wilton, 2009, The causes of misdiagnosis and adverse outcomes in PGD, Hum. Reprod., 10.1093/humrep/den488 Spits, 2009, PGD for monogenic disorders: aspects of molecular biology, Prenat. Diagn., 29, 50, 10.1002/pd.2161 Kuliev, 1998, Preimplantation diagnosis of thalassemias, J. Assist. Reprod. Genet., 15, 219, 10.1023/A:1022571822585 Vrettou, 1999, A widely applicable strategy for single cell genotyping of beta-thalassaemia mutations using DGGE analysis: application to preimplantation genetic diagnosis, Prenat. Diagn., 19, 1209, 10.1002/(SICI)1097-0223(199912)19:13<1209::AID-PD722>3.0.CO;2-6 De Rycke, 2001, Preimplantation genetic diagnosis for sickle-cell anemia and for beta-thalassemia, Prenat. Diagn., 21, 214, 10.1002/1097-0223(200103)21:3<214::AID-PD51>3.0.CO;2-4 Piyamongkol, 2001, Preimplantation genetic diagnostic protocols for alpha- and beta-thalassaemias using multiplex fluorescent PCR, Prenat. Diagn., 21, 753, 10.1002/pd.170 Fiorentino, 2003, The minisequencing method: an alternative strategy for preimplantation genetic diagnosis of single gene disorders, Mol. Hum. Reprod., 9, 399, 10.1093/molehr/gag046 Vrettou, 2004, Real-time PCR for single-cell genotyping in sickle cell and thalassemia syndromes as a rapid, accurate, reliable, and widely applicable protocol for preimplantation genetic diagnosis, Hum. Mutat., 23, 513, 10.1002/humu.20022 Edwards, 2004, Ethics of PGD: thoughts on the consequences of typing HLA in embryos, Reprod. Biomed. Online., 9, 222, 10.1016/S1472-6483(10)62133-5 Fiorentino, 2004, Development and clinical application of a strategy for preimplantation genetic diagnosis of single gene disorders combined with HLA matching, Mol. Hum. Reprod., 10, 445, 10.1093/molehr/gah055 Van de Velde, 2004, Novel universal approach for preimplantation genetic diagnosis of beta-thalassaemia in combination with HLA matching of embryos, Hum. Reprod., 19, 700, 10.1093/humrep/deh153 Kuliev, 2005, Preimplantation diagnosis and HLA typing for haemoglobin disorders, Reprod. Biomed. Online., 11, 362, 10.1016/S1472-6483(10)60845-0 Qureshi, 2005, Outcomes of preimplantation genetic diagnosis therapy in treatment of beta-thalassemia: a retrospective analysis, Ann. N.Y. Acad. Sci., 1054, 500, 10.1196/annals.1345.060 Schroder, 1975, Transplacental passage of blood cells, J. Med. Genet., 12, 230, 10.1136/jmg.12.3.230 Lo, 1997, Presence of fetal DNA in maternal plasma and serum, Lancet, 350, 485, 10.1016/S0140-6736(97)02174-0 Bianchi, 1990, Isolation of fetal DNA from nucleated erythrocytes in maternal blood, Proc. Natl. Acad. Sci. U. S. A., 87, 3279, 10.1073/pnas.87.9.3279 Cheung, 1996, Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood, Nat. Genet., 14, 264, 10.1038/ng1196-264 Kolialexi, 2007, Noninvasive prenatal diagnosis of beta-thalassaemia using individual fetal erythroblasts isolated from maternal blood after enrichment, Prenat. Diagn., 27, 1228, 10.1002/pd.1881 Bianchi, 1999, Fetal cells in the maternal circulation: feasibility for prenatal diagnosis, Br. J. Haematol., 105, 574, 10.1046/j.1365-2141.1999.01383.x Alberry, 2007, Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast, Prenat. Diagn., 27, 415, 10.1002/pd.1700 Lo, 1999, Rapid clearance of fetal DNA from maternal plasma, Am. J. Hum. Genet., 64, 218, 10.1086/302205 Chan, 2004, Size distributions of maternal and fetal DNA in maternal plasma, Clin. Chem., 50, 88, 10.1373/clinchem.2003.024893 Li, 2004, Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms, Clin. Chem., 50, 1002, 10.1373/clinchem.2003.029835 Lo, 1998, Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma, N. Engl. J. Med., 339, 1734, 10.1056/NEJM199812103392402 Lun, 2008, Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma, Clin. Chem., 54, 1664, 10.1373/clinchem.2008.111385 Zimmermann, 2008, Quantification of circulatory fetal DNA in the plasma of pregnant women, Methods. Mol. Biol., 444, 219, 10.1007/978-1-59745-066-9_17 Purwosunu, 2008, Detection and quantification of fetal DNA in maternal plasma by using LightCycler technology, Methods. Mol. Biol., 444, 231, 10.1007/978-1-59745-066-9_18 Amicucci, 2000, Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma, Clin. Chem., 46, 301, 10.1093/clinchem/46.2.301 Chiu, 2002, Prenatal exclusion of beta thalassaemia major by examination of maternal plasma, Lancet, 360, 998, 10.1016/S0140-6736(02)11086-5 Chen, 2001, Fetal DNA analyzed in plasma from a mother's three consecutive pregnancies to detect paternally inherited aneuploidy, Clin. Chem., 47, 937, 10.1093/clinchem/47.5.937 Costa, 2002, New strategy for prenatal diagnosis of X-linked disorders, N. Engl. J. Med., 346, 1502, 10.1056/NEJM200205093461918 Finning, 2002, Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service, Transfusion, 42, 1079, 10.1046/j.1537-2995.2002.00165.x Zhong, 2001, Risk free simultaneous prenatal identification of fetal Rhesus D status and sex by multiplex real-time PCR using cell free fetal DNA in maternal plasma, Swiss. Med. Wkly., 131, 70 Bustamante-Aragones, 2008, New strategy for the prenatal detection/exclusion of paternal cystic fibrosis mutations in maternal plasma, J. Cyst. Fibros., 7, 505, 10.1016/j.jcf.2008.05.006 Ding, 2004, MS analysis of single-nucleotide differences in circulating nucleic acids: application to noninvasive prenatal diagnosis, Proc. Natl. Acad. Sci. U. S. A., 101, 10762, 10.1073/pnas.0403962101 Fucharoen, 2003, Prenatal detection of fetal hemoglobin E gene from maternal plasma, Prenat. Diagn., 23, 393, 10.1002/pd.607 Galbiati, 2008, Peptide-nucleic acid-mediated enriched polymerase chain reaction as a key point for non-invasive prenatal diagnosis of beta-thalassemia, Haematologica, 93, 610, 10.3324/haematol.11895 Gonzalez-Gonzalez, 2002, Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma, Prenat. Diagn., 22, 946, 10.1002/pd.439 Gonzalez-Gonzalez, 2003, Early Huntington disease prenatal diagnosis by maternal semiquantitative fluorescent-PCR, Neurology, 60, 1214, 10.1212/01.WNL.0000056084.13096.8A Li, 2004, Improved prenatal detection of a fetal point mutation for achondroplasia by the use of size-fractionated circulatory DNA in maternal plasma-case report, Prenat. Diagn., 24, 896, 10.1002/pd.1030 Lun, 2008, Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma, Proc. Natl. Acad. Sci. U. S. A., 105, 19920, 10.1073/pnas.0810373105 Nasis, 2004, Improvement in sensitivity of allele-specific PCR facilitates reliable noninvasive prenatal detection of cystic fibrosis, Clin. Chem., 50, 694, 10.1373/clinchem.2003.025981 Papasavva, 2008, Arrayed primer extension for the noninvasive prenatal diagnosis of beta-thalassemia based on detection of single nucleotide polymorphisms, Ann. N. Y. Acad. Sci., 1137, 302, 10.1196/annals.1448.029 Saito, 2000, Prenatal DNA diagnosis of a single-gene disorder from maternal plasma, Lancet, 356, 1170, 10.1016/S0140-6736(00)02767-7 Ding, 2008, Maldi-TOF mass spectrometry for analyzing cell-free fetal DNA in maternal plasma, Methods. Mol. Biol., 444, 253, 10.1007/978-1-59745-066-9_20 Li, 2005, Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma, JAMA, 293, 843, 10.1001/jama.293.7.843 Galbiati, 2008, Peptide-nucleic acid-mediated enriched polymerase chain reaction as a key point for non-invasive prenatal diagnosis of {beta}-thalassemia, Haematologica, 93, 610, 10.3324/haematol.11895 Kurg, 2000, Arrayed primer extension: solid-phase four-color DNA resequencing and mutation detection technology, Genet. Test., 4, 1, 10.1089/109065700316408 Lun, 2008, Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma, Clin. Chem., 54, 1664, 10.1373/clinchem.2008.111385 Zimmermann, 2008, Digital PCR: a powerful new tool for noninvasive prenatal diagnosis?, Prenat. Diagn., 28, 1087, 10.1002/pd.2150 Maddocks, 2009, The SAFE project: towards non-invasive prenatal diagnosis, Biochem. Soc. Trans., 37, 460, 10.1042/BST0370460 Chitty, 2008, SAFE—the Special Non-invasive Advances in Fetal and Neonatal Evaluation Network: aims and achievements, Prenat. Diagn., 28, 83, 10.1002/pd.1929